{"id":64,"date":"2023-11-18T17:55:30","date_gmt":"2023-11-18T16:55:30","guid":{"rendered":"http:\/\/sciencepradipika.fr\/?page_id=64"},"modified":"2026-10-18T17:44:29","modified_gmt":"2026-10-18T15:44:29","slug":"publications-2010-2022","status":"publish","type":"page","link":"https:\/\/sciencepradipika.fr\/index.php\/publications-2010-2022\/","title":{"rendered":"Publications 2010-2022"},"content":{"rendered":"\n

Publications 2014<\/a>–2015<\/a>–2016<\/a>–2017<\/a>–2018<\/a>–2019<\/a>–2020-2022<\/a><\/h4>\n\n\n\n

2020-2022 (return)<\/a><\/h4>\n\n\n\n
    \n
  1. Rossi, J.-F.; Chiang, H.-C.; Lu, Z.-Y.; Levon, K.; van Rhee, F.; Kanhai, K.; Fajgenbaum, D. C. and Klein, B.<\/strong> (2022<\/strong>). Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.<\/em>, Frontiers in immunology 13 : 919489.<\/a><\/li>\n\n\n\n
  2. Rossi, J.-F.; Chiang, H.-C. and Klein, B.<\/strong> (2021<\/strong>). Tocilizumab in Treatment for Patients With COVID-19.<\/em>, JAMA internal medicine 181 : 1018-1019.<\/li>\n\n\n\n
  3. Villard, O.; Armanet, M.; Couderc, G.; Bony, C.; Moreaux, J.; No\u00ebl, D.; De Vos, J.; Klein, B.; Veyrune, J.-L. and Wojtusciszyn, A.<\/strong> (2020<\/strong>). Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features.<\/em>, Stem cell research & therapy 11 : 158.<\/a><\/li>\n<\/ol>\n\n\n\n

    2019 (return)<\/a><\/h4>\n\n\n\n
      \n
    1. Requirand, G.; Robert, N.; Boireau, S.; Vincent, L.; Seckinger, A.; Bouhya, S.; Ceballos, P.; Cartron, G.; Hose, D.; Klein, B. and Moreaux, J.<\/strong> (2019<\/strong>). BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma.<\/em>, Cytometry. Part B, Clinical cytometry 96 : 209-214.<\/a><\/li>\n\n\n\n
    2. Vikova, V.; Jourdan, M.; Robert, N.; Requirand, G.; Boireau, S.; Bruyer, A.; Vincent, L.; Cartron, G.; Klein, B.; Elemento, O.; Kassambara, A. and Moreaux, J.<\/strong> (2019<\/strong>). Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.<\/em>, Theranostics 9 : 540-553.<\/a><\/li>\n\n\n\n
    3. Gourzones, C.; Bellanger, C.; Lamure, S.; Gadacha, O. K.; De Paco, E. G.; Vincent, L.; Cartron, G.; Klein, B. and Moreaux, J.<\/strong> (2019<\/strong>). Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells.<\/em>, Cancers 11.<\/a><\/li>\n<\/ol>\n\n\n\n

      2018 (return)<\/a><\/h4>\n\n\n\n
        \n
      1. Alaterre, E.; Raimbault, S.; Garcia, J.-M.; R\u00e8me, T.; Requirand, G.; Klein, B. and Moreaux, J.<\/strong> (2018<\/strong>). Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry.<\/em>, Cytometry. Part B, Clinical cytometry 94 : 484-492.<\/a><\/li>\n\n\n\n
      2. Bruyer, A.; Maes, K.; Herviou, L.; Kassambara, A.; Seckinger, A.; Cartron, G.; R\u00e8me, T.; Robert, N.; Requirand, G.; Boireau, S.; M\u00fcller-Tidow, C.; Veyrune, J.-L.; Vincent, L.; Bouhya, S.; Goldschmidt, H.; Vanderkerken, K.; Hose, D.; Klein, B.; De Bruyne, E. and Moreaux, J.<\/strong> (2018<\/strong>). DNMTi\/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.<\/em>, British journal of cancer 118 : 1062-1073.<\/a><\/li>\n<\/ol>\n\n\n\n

        2017 (return)<\/a><\/h4>\n\n\n\n
          \n
        1. Jourdan, M.; Robert, N.; Cren, M.; Thibaut, C.; Duperray, C.; Kassambara, A.; Cogn\u00e9, M.; Tarte, K.; Klein, B. and Moreaux, J.<\/strong> (2017<\/strong>). Characterization of human FCRL4-positive B cells.<\/em>, PloS one 12 : e0179793.<\/a><\/li>\n\n\n\n
        2. Kassambara, A.; Jourdan, M.; Bruyer, A.; Robert, N.; Pantesco, V.; Elemento, O.; Klein, B. and Moreaux, J.<\/strong> (2017<\/strong>). Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.<\/em>, Nucleic acids research 45 : 5639-5652.<\/a><\/li>\n\n\n\n
        3. Schoenhals, M.; Jourdan, M.; Bruyer, A.; Kassambara, A.; Klein, B. and Moreaux, J.<\/strong> (2017<\/strong>). Hypoxia favors the generation of human plasma cells.<\/em>, Cell cycle (Georgetown, Tex.) 16 : 1104-1117.<\/a><\/li>\n\n\n\n
        4. Alaterre, E.; Raimbault, S.; Goldschmidt, H.; Bouhya, S.; Requirand, G.; Robert, N.; Boireau, S.; Seckinger, A.; Hose, D.; Klein, B. and Moreaux, J.<\/strong> (2017<\/strong>). CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.<\/em>, Oncotarget 8 : 98931-98944<\/a>.<\/li>\n\n\n\n
        5. Viziteu, E.; Klein, B.; Basbous, J.; Lin, Y.-L.; Hirtz, C.; Gourzones, C.; Tiers, L.; Bruyer, A.; Vincent, L.; Grandmougin, C.; Seckinger, A.; Goldschmidt, H.; Constantinou, A.; Pasero, P.; Hose, D. and Moreaux, J.<\/strong> (2017<\/strong>). RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.<\/em>, Leukemia 31 : 2104-2113.<\/a><\/li>\n<\/ol>\n\n\n\n

          2016 (return)<\/a><\/h4>\n\n\n\n
            \n
          1. Viziteu, E.; Grandmougin, C.; Goldschmidt, H.; Seckinger, A.; Hose, D.; Klein, B. and Moreaux, J.<\/strong> (2016<\/strong>). Chetomin, targeting HIF-1\u03b1\/p300 complex, exhibits antitumour activity in multiple myeloma.<\/em>, British journal of cancer 114 : 519-23.<\/a><\/li>\n\n\n\n
          2. Viziteu, E.; Kassambara, A.; Pasero, P.; Klein, B. and Moreaux, J.<\/strong> (2016<\/strong>). RECQ helicases are deregulated in hematological malignancies in association with a prognostic value.<\/em>, Biomarker research 4 : 3.<\/a><\/li>\n\n\n\n
          3. Herviou, L.; Cavalli, G.; Cartron, G.; Klein, B. and Moreaux, J.<\/strong> (2016<\/strong>). EZH2 in normal hematopoiesis and hematological malignancies.<\/em>, Oncotarget 7 : 2284-96.<\/a><\/li>\n\n\n\n
          4. J<\/strong>ourdan, M.; Cren, M.; Schafer, P.; Robert, N.; Duperray, C.; Vincent, L.; Ceballos, P.; Cartron, G.; Rossi, J.-F.; Moreaux, J.; Chopra, R. and Klein, B.<\/strong> (2016<\/strong>). Differential effects of lenalidomide during plasma cell differentiation.<\/em>, Oncotarget 7 : 28096-111.<\/a><\/li>\n\n\n\n
          5. Schoenhals, M.; Jourdan, M.; Seckinger, A.; Pantesco, V.; Hose, D.; Kassambara, A.; Moreaux, J. and Klein, B.<\/strong> (2016<\/strong>). Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage.<\/em>, Cell cycle (Georgetown, Tex.) 15 : 1919-28.<\/a><\/li>\n<\/ol>\n\n\n\n

            2015 (return)<\/a><\/h4>\n\n\n\n
              \n
            1. Bolomsky, A.; Hose, D.; Schreder, M.; Seckinger, A.; Lipp, S.; Klein, B.; Heintel, D.; Ludwig, H. and Zojer, N.<\/strong> (2015<\/strong>). Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.<\/em>, Journal of hematology & oncology 8 : 10.<\/a><\/li>\n\n\n\n
            2. Bret, C.; Klein, B.; Cartron, G.; Schved, J.-F.; Constantinou, A.; Pasero, P. and Moreaux, J. <\/strong>(2015<\/strong>). DNA repair in diffuse large B-cell lymphoma: a molecular portrait.<\/em>, British journal of haematology 169 : 296-9.<\/a><\/li>\n\n\n\n
            3. Hassen, W.; Kassambara, A.; Reme, T.; Sahota, S.; Seckinger, A.; Vincent, L.; Cartron, G.; Moreaux, J.; Hose, D. and Klein, B.<\/strong> (2015<\/strong>). Drug metabolism and clearance system in tumor cells of patients with multiple myeloma.<\/em>, Oncotarget 6 : 6431-47.<\/a><\/li>\n\n\n\n
            4. Kassambara, A.; R\u00e8me, T.; Jourdan, M.; Fest, T.; Hose, D.; Tarte, K. and Klein, B.<\/strong> (2015<\/strong>). GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.<\/em>, PLoS computational biology 11 : e1004077.<\/a><\/li>\n\n\n\n
            5. Maes, K.; De Smedt, E.; Kassambara, A.; Hose, D.; Seckinger, A.; Van Valckenborgh, E.; Menu, E.; Klein, B.; Vanderkerken, K.; Moreaux, J. and De Bruyne, E.<\/strong> (2015<\/strong>). In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.<\/em>, Oncotarget 6 : 3319-34.<\/a><\/li>\n\n\n\n
            6. Rossi, J.-F.; Lu, Z.-Y.; Jourdan, M. and Klein, B.<\/strong> (2015<\/strong>). Interleukin-6 as a therapeutic target.<\/em>, Clinical cancer research : an official journal of the American Association for Cancer Research 21 : 1248-57.<\/a><\/li>\n\n\n\n
            7. Seckinger, A.; Mei\u00dfner, T.; Moreaux, J.; Benes, V.; Hillengass, J.; Castoldi, M.; Zimmermann, J.; Ho, A. D.; Jauch, A.; Goldschmidt, H.; Klein, B. and Hose, D.<\/strong> (2015<\/strong>). miRNAs in multiple myeloma–a survival relevant complex regulator of gene expression.<\/em>, Oncotarget 6 : 39165-83.<\/a><\/li>\n\n\n\n
            8. Vincent, L.; Ceballos, P.; Plassot, C.; M\u00e9niane, J. C.; Quittet, P.; Navarro, R.; Cyteval, C.; Szablewski, V.; Lu, Z. Y.; Kanouni, T.; Moreaux, J.; Cartron, G.; Klein, B. and Fegueux, N. <\/strong>(2015<\/strong>). Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma.<\/em>, Blood cancer journal 5 : e341.<\/a><\/li>\n\n\n\n
            9. Waizenegger, J. S.; Ben-Batalla, I.; Weinhold, N.; Meissner, T.; Wroblewski, M.; Janning, M.; Riecken, K.; Binder, M.; Atanackovic, D.; Taipaleenmaeki, H.; Schewe, D.; Sawall, S.; Gensch, V.; Cubas-Cordova, M.; Seckinger, A.; Fiedler, W.; Hesse, E.; Kr\u00f6ger, N.; Fehse, B.; Hose, D.; Klein, B.; Raab, M. S.; Pantel, K.; Bokemeyer, C. and Loges, S.<\/strong> (2015<\/strong>). Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.<\/em>, Leukemia 29 : 696-704.<\/li>\n\n\n\n
            10. Weinhold, N.; Meissner, T.; Johnson, D. C.; Seckinger, A.; Moreaux, J.; F\u00f6rsti, A.; Chen, B.; Nickel, J.; Chubb, D.; Rawstron, A. C.; Doughty, C.; Dahir, N. B.; Begum, D. B.; Young, K.; Walker, B. A.; Hoffmann, P.; N\u00f6then, M. M.; Davies, F. E.; Klein, B.; Goldschmidt, H.; Morgan, G. J.; Houlston, R. S.; Hose, D. and Hemminki, K. <\/strong>(2015<\/strong>). The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.<\/em>, Haematologica 100 : e110-3.<\/a><\/li>\n<\/ol>\n\n\n\n

              2014 (return)<\/a><\/h4>\n\n\n\n
                \n
              1. Auger, S.; Orsini, M.; C\u00e9ballos, P.; Fegueux, N.; Kanouni, T.; Caumes, B.; Klein, B.; Villalba, M. and Rossi, J.-F.<\/strong> (2014<\/strong>). Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival.<\/em>, European journal of haematology 92 : 421-8.<\/a><\/li>\n\n\n\n
              2. Bou Samra, E.; Klein, B.; Commes, T. and Moreaux, J.<\/strong> (2014<\/strong>). Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.<\/em>, BioMed research international 2014 : 423174.<\/a><\/li>\n\n\n\n
              3. Jourdan, M.; Cren, M.; Robert, N.; Bollor\u00e9, K.; Fest, T.; Duperray, C.; Guilloton, F.; Hose, D.; Tarte, K. and Klein, B.<\/strong> (2014<\/strong>). IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.<\/em>, Leukemia 28 : 1647-56.<\/a><\/li>\n\n\n\n
              4. Kassambara, A.; Gourzones-Dmitriev, C.; Sahota, S.; R\u00e8me, T.; Moreaux, J.; Goldschmidt, H.; Constantinou, A.; Pasero, P.; Hose, D. and Klein, B.<\/strong> (2014<\/strong>). A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy.<\/em>, Oncotarget 5 : 2487-98<\/a>.<\/li>\n\n\n\n
              5. Moreaux, J.; Bruyer, A.; Veyrune, J.-L.; Goldschmidt, H.; Hose, D. and Klein, B<\/strong>. (2014<\/strong>). DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine.<\/em>, British journal of haematology 164 : 613-6.<\/a><\/li>\n\n\n\n
              6. Wagner, V.; Hose, D.; Seckinger, A.; Weiz, L.; Mei\u00dfner, T.; R\u00e8me, T.; Breitkreutz, I.; Podar, K.; Ho, A. D.; Goldschmidt, H.; Kr\u00e4mer, A.; Klein, B. and Raab, M. S.<\/strong> (2014<\/strong>). Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.<\/em>, Oncotarget 5 : 10237-50.<\/a><\/li>\n\n\n\n
              7. Waizenegger, J. S.; Ben-Batalla, I.; Weinhold, N.; Meissner, T.; Wroblewski, M.; Janning, M.; Riecken, K.; Binder, M.; Atanackovic, D.; Taipaleenmaeki, H.; Schewe, D.; Sawall, S.; Gensch, V.; Cubas-Cordova, M.; Seckinger, A.; Fiedler, W.; Hesse, E.; Kr\u00f6ger, N.; Fehse, B.; Hose, D.; Klein, B.; Raab, M. S.; Pantel, K.; Bokemeyer, C. and Loges, S.<\/strong> (2015<\/strong>). Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.<\/em>, Leukemia 29 : 696-704.<\/a><\/li>\n<\/ol>\n\n\n\n

                <\/p>\n","protected":false},"excerpt":{"rendered":"

                Publications 2014–2015–2016–2017–2018–2019–2020-2022 2020-2022 (return) 2019 (return) 2018 (return) 2017 (return) 2016 (return) 2015 (return) 2014 (return)<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-64","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/pages\/64","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/comments?post=64"}],"version-history":[{"count":12,"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/pages\/64\/revisions"}],"predecessor-version":[{"id":99,"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/pages\/64\/revisions\/99"}],"wp:attachment":[{"href":"https:\/\/sciencepradipika.fr\/index.php\/wp-json\/wp\/v2\/media?parent=64"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}